Decrease of resistance to imatinib in leukaemia.
| Publicado en: | Lancet Vol. 359; no. 9319; pp. 1776 - 1778 |
|---|---|
| Autores principales: | , , |
| Formato: | letter Journal Article |
| Publicado: |
Lancet
5/18/2002
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=136966925&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 136966925 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 01406736 LAN jtl: Lancet issn: 01406736 maglogo: N pubinfo: dt: 5/18/2002 vid: 359 iid: 9319 pid: 1297 pub: Lancet place: Philadelphia, Pennsylvania artinfo: ui: 136966925 136966925 NLM12049890 136966925 10.1016/s0140-6736(02)08622-1 NLM12049890 136966925 ppf: 1776 ppct: 2 formats: fmt: @attributes: type: P tig: atl: Decrease of resistance to imatinib in leukaemia. aug: au: Bakalova, Rumiana Zhelev, Zhivko Ohba, Hideki sug: subj: Heterocyclic Compounds Therapeutic Use Proteins Therapeutic Use Leukemia, Myeloid, Chronic Drug Therapy Mutation Enzyme Inhibitors Therapeutic Use Benzamides Proteins Drug Synergism Protein-Tyrosine Kinases Antagonists and Inhibitors pubtype: Academic Journal doctype: letter Journal Article ougenre: Unknown ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|